IRISTRO Trademark

Trademark Overview


On Thursday, May 16, 2019, a trademark application was filed for IRISTRO with the United States Patent and Trademark Office. The USPTO has given the IRISTRO trademark a serial number of 79263048. The federal status of this trademark filing is REGISTERED as of Tuesday, February 11, 2020. This trademark is owned by Glaxo Group Limited. The IRISTRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
iristro

General Information


Serial Number79263048
Word MarkIRISTRO
Filing DateThursday, May 16, 2019
Status700 - REGISTERED
Status DateTuesday, February 11, 2020
Registration Number5980361
Registration DateTuesday, February 11, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Friday, July 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 23, 2019APPLICATION FILING RECEIPT MAILED
Thursday, August 1, 2019ASSIGNED TO EXAMINER
Thursday, July 18, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, August 24, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Monday, September 23, 2019NON-FINAL ACTION WRITTEN
Saturday, September 28, 2019REFUSAL PROCESSED BY MPU
Wednesday, October 16, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 5, 2019NON-FINAL ACTION WRITTEN
Tuesday, August 6, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 24, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, September 28, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, October 19, 2019REFUSAL PROCESSED BY IB
Wednesday, November 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2019PUBLISHED FOR OPPOSITION
Thursday, October 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 23, 2019ASSIGNED TO LIE
Tuesday, November 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, May 11, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 2, 2020FINAL DISPOSITION PROCESSED
Tuesday, February 11, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, June 2, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 19, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 28, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, May 30, 2025NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, February 11, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED